Keyphrases
Label-free
56%
Human Breast Cancer
56%
Extracellular Vesicles
56%
Breast Tissue
55%
Optical Signature
52%
PS-OCT
52%
Community Hospital
52%
Large Community
52%
Breast Reconstruction
33%
Tumor Microenvironment
30%
Breast Cancer
30%
Invasive Ductal Carcinoma
28%
Re-excision Rate
28%
Wire Localization
26%
Radioactive Seed Localization
26%
Nonlinear Optical
26%
Liquid Biopsy
26%
Cavity Shave Margins
26%
Tissue Biopsy
26%
Tumor Quantification
26%
Infrared Spectroscopic Imaging
26%
Machine Learning
26%
Nonlinear Imaging
26%
Polarization-insensitive
26%
Intraoperative Visualization
26%
Tissue Type
26%
Unsupervised Learning
26%
Cancer-related
26%
Surgical Margin
26%
Non-palpable Breast Lesions
26%
Fibroadipose Tissue
17%
Differentiation Model
17%
Performance Measures
13%
Analysis pipeline
13%
Analytical Performance
13%
Biological Materials
13%
Histological Analysis
13%
Biomedical Analysis
13%
Fidelity Measures
13%
Signature Discovery
13%
Fourier Transform Infrared Spectroscopy (FT-IR)
13%
In-depth Data
13%
Infrared Spectral
13%
Theoretical Understanding
13%
Breast Cancer Pathology
13%
Spectral Fidelity
13%
Spectral Acquisition
13%
Infrared Imaging
13%
Technological Progress
13%
Spatial Metrics
13%
Medicine and Dentistry
Breast Cancer
100%
Breast Tissue
75%
Optical Coherence Tomography
52%
Malignant Neoplasm
43%
Histopathology
34%
Tumor Microenvironment
34%
Biopsy Technique
31%
Quadrantectomy
28%
Radioactive Seed
26%
Surgical Margin
26%
Tissue (Anatomy)
26%
Intraductal Carcinoma
26%
Liquid Biopsy
26%
Spectroscopic Imaging
26%
Breast Lesion
26%
Ex Vivo
26%
Breast Carcinoma
22%
Stroma
20%
Autofluorescence
17%
Cancer Biomarkers
17%
Cancer Diagnosis
16%
Breast Reduction
13%
Biocompatible Material
13%
Infrared Imaging
13%
Infrared Spectroscopy
13%
Adipose Tissue
11%
Tumor Invasion
10%
Needle Biopsy
10%
Nonlinear Optical Microscopy
8%
Breast Tumor
8%
Lifespan
8%
Urinary System
8%
Stage 2 Cancer
8%
Cancer Tissue
8%
Metastatic Carcinoma
8%
Tissue Differentiation
5%
Neoplasm
5%
Surgical Planning
5%
Cell Function
5%
Cancer Growth
5%
Cancer Prognosis
5%
Biological Marker
5%